![Denis Patrick](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Denis Patrick
Private Equity Investor at PFIZER, INC.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jim Broderick | M | 55 |
Palleon Pharmaceuticals, Inc.
![]() Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | 9 years |
Albert Bourla | M | 62 | 31 years | |
Stephen Worland | M | 66 |
eFFECTOR Therapeutics Operations, Inc.
![]() eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | 12 years |
Sue Desmond-Hellmann | M | 66 | 4 years | |
Frank G. Haluska | M | 64 |
Kestrel Therapeutics, Inc.
![]() Kestrel Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kestrel Therapeutics, Inc. operates as a biotechnology development company. The company is based in Wayland, MA. The CEO of the company is Frank G. Haluska. | - |
Douglas Lankler | M | 58 | 25 years | |
Colin Goddard | M | 64 |
FoRx Therapeutics AG
![]() FoRx Therapeutics AG Pharmaceuticals: MajorHealth Technology FoRx Therapeutics AG operates as a biotechnology company developing a new generation of cancer drugs focusing on novel deoxyribonucleic acid (DNA) Replication Stress pathways activated in cancer. The firm also provides research and development services. The company was founded by Thanos Halazonetis and Sotirios K. Sotiriou in 2019 and is headquartered in Basel, Switzerland.
MISSION Therapeutics Ltd.
![]() MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | 9 years |
Margaret M. Madden | F | - | - | |
Alana McNulty | F | 61 |
eFFECTOR Therapeutics Operations, Inc.
![]() eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | 12 years |
Michael Baran | M | - |
Pfizer Venture Investments LLC
![]() Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments LLC (Pfizer Ventures Investments) is a venture capital subsidiary of Pfizer Inc. founded in 2001. The firm is headquartered in New York. | 16 years |
Sally Susman | F | 62 | 17 years | |
Joseph Echevarria | M | 66 | 9 years | |
Stephen Philip Jackson | M | - |
MISSION Therapeutics Ltd.
![]() MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | 13 years |
Dan Littman | M | 71 | 6 years | |
Rady Johnson | M | 63 | 30 years | |
Eyal Gottlieb | M | - |
Metabomed Ltd.
![]() Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | 11 years |
David Johnson | M | 59 |
Palleon Pharmaceuticals, Inc.
![]() Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | 3 years |
Jim Smith | M | 64 | 10 years | |
James B. Summers | M | - |
MISSION Therapeutics Ltd.
![]() MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | 5 years |
Christopher O’Donnell | M | 55 |
Pfizer Venture Investments LLC
![]() Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments LLC (Pfizer Ventures Investments) is a venture capital subsidiary of Pfizer Inc. founded in 2001. The firm is headquartered in New York. | 6 years |
Rana Al-Hallaq | M | - |
Pfizer Venture Investments LLC
![]() Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments LLC (Pfizer Ventures Investments) is a venture capital subsidiary of Pfizer Inc. founded in 2001. The firm is headquartered in New York. | 6 years |
Thanos Halazonetis | M | - |
FoRx Therapeutics AG
![]() FoRx Therapeutics AG Pharmaceuticals: MajorHealth Technology FoRx Therapeutics AG operates as a biotechnology company developing a new generation of cancer drugs focusing on novel deoxyribonucleic acid (DNA) Replication Stress pathways activated in cancer. The firm also provides research and development services. The company was founded by Thanos Halazonetis and Sotirios K. Sotiriou in 2019 and is headquartered in Basel, Switzerland. | 5 years |
Sotirios K. Sotiriou | M | - |
FoRx Therapeutics AG
![]() FoRx Therapeutics AG Pharmaceuticals: MajorHealth Technology FoRx Therapeutics AG operates as a biotechnology company developing a new generation of cancer drugs focusing on novel deoxyribonucleic acid (DNA) Replication Stress pathways activated in cancer. The firm also provides research and development services. The company was founded by Thanos Halazonetis and Sotirios K. Sotiriou in 2019 and is headquartered in Basel, Switzerland. | 5 years |
John Hennessy | M | - |
Palleon Pharmaceuticals, Inc.
![]() Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | - |
Hugo Beekman | M | - |
Evolveimmune Therapeutics, Inc.
![]() Evolveimmune Therapeutics, Inc. BiotechnologyHealth Technology EvolveImmune Therapeutics Inc. engages in the provision of healthcare services. It offers immunotherapy platform to develop molecules for the treatment of oncology and immune diseases. The company was founded in 2019 and is headquartered in Westport, CT. | - |
Alessandra di Bacco | F | - |
Evolveimmune Therapeutics, Inc.
![]() Evolveimmune Therapeutics, Inc. BiotechnologyHealth Technology EvolveImmune Therapeutics Inc. engages in the provision of healthcare services. It offers immunotherapy platform to develop molecules for the treatment of oncology and immune diseases. The company was founded in 2019 and is headquartered in Westport, CT. | - |
Helen Hobbs | M | 71 | 13 years | |
James Quincey | M | 59 | 4 years | |
Michael G. Moore | M | - |
MISSION Therapeutics Ltd.
![]() MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | 12 years |
Anker Gunvald Lundemose | M | 63 |
MISSION Therapeutics Ltd.
![]() MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | - |
Shantanu Narayen | M | 60 | 11 years | |
Barbara Dalton | M | 69 |
Pfizer Venture Investments LLC
![]() Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments LLC (Pfizer Ventures Investments) is a venture capital subsidiary of Pfizer Inc. founded in 2001. The firm is headquartered in New York. | 17 years |
Deepa Pakianathan | M | 59 |
Palleon Pharmaceuticals, Inc.
![]() Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | 4 years |
Ronald Blaylock | M | 64 | 7 years | |
Scott Gottlieb | M | 51 | 5 years | |
Stephen Bloch | M | 62 |
Evolveimmune Therapeutics, Inc.
![]() Evolveimmune Therapeutics, Inc. BiotechnologyHealth Technology EvolveImmune Therapeutics Inc. engages in the provision of healthcare services. It offers immunotherapy platform to develop molecules for the treatment of oncology and immune diseases. The company was founded in 2019 and is headquartered in Westport, CT. | 4 years |
Suzanne Johnson | F | 66 | 17 years | |
Susan Hockfield | M | 73 | 4 years | |
Bryan Supran | M | - | 8 years | |
Ira R. Harkavy | M | 75 |
University of Pennsylvania
| 32 years |
Jonathan Hepple | M | 53 |
MISSION Therapeutics Ltd.
![]() MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | 3 years |
Aida Habtezion | M | - | 3 years | |
Patrice Ettinger | F | - | - | |
Christopher J. Stevo | M | - | 3 years | |
Aamir Malik | M | 48 | 3 years | |
Alexandre de Germay | M | - | 1 years | |
Mike McDermott | M | 58 | 21 years | |
Jerica Pitts | F | - | 3 years | |
Markus Green | M | - | 18 years | |
Annaliesa Anderson | M | - | 17 years | |
Steve Danehy | M | - | 12 years | |
Lori Hu | F | 38 |
Palleon Pharmaceuticals, Inc.
![]() Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | 6 years |
John DeYoung | M | 61 | 33 years | |
Chris Boshoff | M | - | - | |
Mikael Dolsten | M | 65 | 15 years | |
Ronen Tamir | M | 57 | 5 years | |
Deborah Harland | M | 64 |
MISSION Therapeutics Ltd.
![]() MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | - |
Bobby G. Soni | M | 53 |
MISSION Therapeutics Ltd.
![]() MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | - |
Graziano Seghezzi | M | 55 |
MISSION Therapeutics Ltd.
![]() MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | - |
Lidia Fonseca | F | 55 | - | |
Elaine Jones | M | 69 |
MISSION Therapeutics Ltd.
![]() MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | - |
Maria Rivas | M | 60 | 2 years | |
Karan Takhar | M | 32 |
Palleon Pharmaceuticals, Inc.
![]() Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | - |
Rajeev Dadoo | M | 54 |
Palleon Pharmaceuticals, Inc.
![]() Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | - |
François-Maurice Garnier | M | 62 | 21 years | |
Suneet Varma | M | 55 | 23 years | |
Maria Gabriella Camboni | M | 66 |
MISSION Therapeutics Ltd.
![]() MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | - |
Jayson Punwani | M | - |
Palleon Pharmaceuticals, Inc.
![]() Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | - |
David Denton | M | 59 | 2 years | |
Avery Waite | F | - | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jeffrey Kindler | M | 68 | 8 years | |
Ian Read | M | 71 | 41 years | |
William Steere | M | 88 | 28 years | |
David Vurgait | M | 59 |
University of Pennsylvania
| 1 years |
Amy Schulman | F | 63 | 6 years | |
George A. Lorch | M | 82 | 15 years | |
Dennis Ausiello | M | 78 | 13 years | |
Scott M. Gallin | M | 51 |
University of Pennsylvania
| 5 years |
John W. Glomb | M | - |
University of Pennsylvania
| 12 years |
Helen Remeza | M | - |
University of Pennsylvania
| 5 years |
Sassan Alizadeh | M | - |
University of Pennsylvania
| 7 years |
Everett Cunningham | M | 57 | 9 years | |
Gregory Z. Rush | M | - |
University of Pennsylvania
| 4 years |
Yi Ning Zhao | M | 53 | 8 years | |
Jennifer Schroeder | F | - | 20 years | |
Joseph Arena | M | 69 | 3 years | |
Robert Landry | M | 60 | 4 years | |
John Mascotte | M | 84 | 4 years | |
Mace Rothenberg | M | 67 | 13 years | |
Lisa Granick | F | - |
University of Pennsylvania
| 2 years |
Frank D'Amelio | M | 66 | 14 years | |
Stephen W. Sanger | M | 78 | 9 years | |
Michael Brown | M | 83 | 16 years | |
William Herbert Gray | M | 82 | 13 years | |
Robert N. Burt | M | 86 | 11 years | |
James Kilts | M | 76 | 13 years | |
Wyllie Cornwell | M | 76 | 23 years | |
Frances Fergusson | M | 79 | 9 years | |
Freda Lewis-Hall | M | 69 | 11 years | |
Lori McNeill | F | 51 | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 86 | 86.00% |
United Kingdom | 11 | 11.00% |
Switzerland | 3 | 3.00% |
Israel | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Denis Patrick
- Personal Network